List of patents in the Immunology industry

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11633739 Droplet-based assay system	Patent 11633739 was granted and assigned to Bio-Rad Laboratories on April, 2023 by the United States Patent and Trademark Office.	Bio-Rad Laboratories	Bio-Rad Laboratories	United States Patent and Trademark Office	11633739	April 25, 2023
‌ US Patent 9764322 System for generating droplets with pressure monitoring	Patent 9764322 was granted and assigned to Bio-Rad Laboratories on September, 2017 by the United States Patent and Trademark Office.	Bio-Rad Laboratories	Bio-Rad Laboratories	United States Patent and Trademark Office	9764322	September 19, 2017
‌ US Patent 9500664 Droplet generation for droplet-based assays	Patent 9500664 was granted and assigned to Bio-Rad Laboratories on November, 2016 by the United States Patent and Trademark Office.		Bio-Rad Laboratories	United States Patent and Trademark Office	9500664	November 22, 2016
‌ US Patent 9216392 System for forming an array of emulsions	Patent 9216392 was granted and assigned to Bio-Rad Laboratories on December, 2015 by the United States Patent and Trademark Office.		Bio-Rad Laboratories	United States Patent and Trademark Office	9216392	December 22, 2015
‌ US Patent 7205156 Probes for a gas phase ion spectrometer	Patent 7205156 was granted and assigned to Bio-Rad Laboratories on April, 2007 by the United States Patent and Trademark Office.		Bio-Rad Laboratories	United States Patent and Trademark Office	7205156	April 17, 2007
‌ US Patent 7479631 Probes for a gas phase ion spectrometer	Patent 7479631 was granted and assigned to Bio-Rad Laboratories on January, 2009 by the United States Patent and Trademark Office.		Bio-Rad Laboratories	United States Patent and Trademark Office	7479631	January 20, 2009
‌ US Patent 9644016 Soluble notch receptor proproteins and methods of use thereof	Patent 9644016 was granted and assigned to CytomX Therapeutics on May, 2017 by the United States Patent and Trademark Office.	CytomX Therapeutics	CytomX Therapeutics	United States Patent and Trademark Office	9644016	May 9, 2017
‌ US Patent 11275015 System and method for retrieving and analyzing particles	Patent 11275015 was granted and assigned to Bio-Rad Laboratories on March, 2022 by the United States Patent and Trademark Office.	Bio-Rad Laboratories	Bio-Rad Laboratories	United States Patent and Trademark Office	11275015	March 15, 2022
‌ US Patent 8979818 Method and apparatus for the delivery of polynucleotide vaccines to mammalian skin	Patent 8979818 was granted and assigned to Cellectis on March, 2015 by the United States Patent and Trademark Office.		Cellectis	United States Patent and Trademark Office	8979818	March 17, 2015
‌ US Patent 10513549 Cleavage-activatable interferon-alpha proprotein	Patent 10513549 was granted and assigned to CytomX Therapeutics on December, 2019 by the United States Patent and Trademark Office.	CytomX Therapeutics	CytomX Therapeutics	United States Patent and Trademark Office	10513549	December 24, 2019
‌ US Patent 9126160 System for forming an array of emulsions	Patent 9126160 was granted and assigned to Bio-Rad Laboratories on September, 2015 by the United States Patent and Trademark Office.		Bio-Rad Laboratories	United States Patent and Trademark Office	9126160	September 8, 2015
‌ US Patent 10301380 Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof	Patent 10301380 was granted and assigned to CytomX Therapeutics on May, 2019 by the United States Patent and Trademark Office.	CytomX Therapeutics	CytomX Therapeutics	United States Patent and Trademark Office	10301380	May 28, 2019
‌ US Patent 11744898 Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods	Patent 11744898 was granted and assigned to Nektar Therapeutics on September, 2023 by the United States Patent and Trademark Office.	Nektar Therapeutics	Nektar Therapeutics	United States Patent and Trademark Office	11744898	September 5, 2023
‌ US Patent 8993266 Proproteins activatable interferon alpha	Patent 8993266 was granted and assigned to CytomX Therapeutics on March, 2015 by the United States Patent and Trademark Office.	CytomX Therapeutics	CytomX Therapeutics	United States Patent and Trademark Office	8993266	March 31, 2015
‌ US Patent 11747327 Compositions and methods for molecular labeling	Patent 11747327 was granted and assigned to Bio-Rad Laboratories on September, 2023 by the United States Patent and Trademark Office.	Bio-Rad Laboratories	Bio-Rad Laboratories	United States Patent and Trademark Office	11747327	September 5, 2023
‌ US Patent 11667687 Masked activatable interferon constructs	Patent 11667687 was granted and assigned to CytomX Therapeutics on June, 2023 by the United States Patent and Trademark Office.	CytomX Therapeutics	CytomX Therapeutics	United States Patent and Trademark Office	11667687	June 6, 2023
‌ US Patent 9623384 System for transporting emulsions from an array to a detector	Patent 9623384 was granted and assigned to Bio-Rad Laboratories on April, 2017 by the United States Patent and Trademark Office.		Bio-Rad Laboratories	United States Patent and Trademark Office	9623384	April 18, 2017
‌ US Patent 11472875 Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof		CytomX Therapeutics	CytomX Therapeutics	United States Patent and Trademark Office	11472875	October 18, 2022
‌ US Patent 9089844 System for forming emulsions	Patent 9089844 was granted and assigned to Bio-Rad Laboratories on July, 2015 by the United States Patent and Trademark Office.		Bio-Rad Laboratories	United States Patent and Trademark Office	9089844	July 28, 2015
‌ US Patent 11351510 Microfluidic devices	Patent 11351510 was granted and assigned to Bio-Rad Laboratories on June, 2022 by the United States Patent and Trademark Office.	Bio-Rad Laboratories	Bio-Rad Laboratories	United States Patent and Trademark Office	11351510	June 7, 2022
‌ US Patent 11548944 Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof	Patent 11548944 was granted and assigned to CytomX Therapeutics on January, 2023 by the United States Patent and Trademark Office.	CytomX Therapeutics	CytomX Therapeutics	United States Patent and Trademark Office	11548944	January 10, 2023
‌ US Patent 11548943 Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof	Patent 11548943 was granted and assigned to CytomX Therapeutics on January, 2023 by the United States Patent and Trademark Office.	CytomX Therapeutics	CytomX Therapeutics	United States Patent and Trademark Office	11548943	January 10, 2023
‌ US Patent 7356440 Method and business process for the estimation of erosion costs in assemble-to-order manufacturing operations	Patent 7356440 was granted and assigned to Rapt on April, 2008 by the United States Patent and Trademark Office.		RAPT Therapeutics	United States Patent and Trademark Office	7356440	April 8, 2008
‌ US Patent 11358147 System and method for isolating and analyzing cells	Patent 11358147 was granted and assigned to Bio-Rad Laboratories on June, 2022 by the United States Patent and Trademark Office.	Bio-Rad Laboratories	Bio-Rad Laboratories	United States Patent and Trademark Office	11358147	June 14, 2022
‌ US Patent 10927407 Systems and methods for handling microfluidic droplets	Patent 10927407 was granted and assigned to Bio-Rad Laboratories on February, 2021 by the United States Patent and Trademark Office.	Bio-Rad Laboratories	Bio-Rad Laboratories	United States Patent and Trademark Office	10927407	February 23, 2021

...

Results per page:

1,371 results

0 selected

1,371 results

0 selected